These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30894410)

  • 1. Ovarian Cancer Maintenance: Practice-Changing Data Calls for Changing Practice.
    Randall LM; Birrer MJ; Herzog TJ
    Oncologist; 2019 May; 24(5):576-579. PubMed ID: 30894410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Therapies for Ovarian Cancer.
    Armstrong DK
    J Natl Compr Canc Netw; 2018 May; 16(5S):632-635. PubMed ID: 29784743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selecting new upfront regimens for advanced ovarian cancer with biomarker guidance.
    Chan JK; Liang SY; Kapp DS; Chan JE; Herzog TJ; Coleman RL; Monk BJ; Richardson MT
    Gynecol Oncol; 2020 Dec; 159(3):604-606. PubMed ID: 32994055
    [No Abstract]   [Full Text] [Related]  

  • 4. SEOM clinical guideline in ovarian cancer (2020).
    Redondo A; Guerra E; Manso L; Martin-Lorente C; Martinez-Garcia J; Perez-Fidalgo JA; Varela MQ; Rubio MJ; Barretina-Ginesta MP; Gonzalez-Martin A
    Clin Transl Oncol; 2021 May; 23(5):961-968. PubMed ID: 33515422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PARP (Poly(ADP-Ribose) Polymerase) Inhibitors in Platinum-Sensitive Recurrent Ovarian Cancer: A Meta-Analysis of Randomized Controlled Trials.
    Al Hadidi S; Aburahma A; Badami S; Upadhaya S
    Oncol Res Treat; 2018; 41(4):226-235. PubMed ID: 29562224
    [No Abstract]   [Full Text] [Related]  

  • 6. Switch maintenance therapy for advanced bladder cancer: A paradigm shift in 2020.
    Chawla NS; Malhotra J; Pal SK
    Cancer Treat Res Commun; 2020; 24():100202. PubMed ID: 32805533
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical Trials of Novel Targeted Therapies in Ovarian Cancer: Moving Beyond Poly ADP Ribose Polymerase (PARP) Inhibitors.
    Guo Q; Yang Q; Li J; Liu G; Nikoulin I; Jia S
    Curr Pharm Biotechnol; 2018; 19(14):1114-1121. PubMed ID: 30585545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current treatment strategies for ovarian cancer in the East Asian Gynecologic Oncology Trial Group (EAGOT).
    Kobayashi Y; Shimada M; Tamate M; Cho HW; Zhu J; Chou HH; Kajiyama H; Okamoto A; Aoki D; Kang S; Lee JW; Kim JW; Kim JH; Lin Z; Liu J; Wu X; Lai HC; Chang TC; Lai CH; Kim YM; Enomoto T
    J Gynecol Oncol; 2024 May; 35(3):e87. PubMed ID: 38606827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results from a Monocentric Long-Term Analysis of 23 Patients with Ovarian Sertoli-Leydig Cell Tumors.
    Gouy S; Arfi A; Maulard A; Pautier P; Bentivegna E; Leary A; Chargari C; Genestie C; Morice P
    Oncologist; 2019 May; 24(5):702-709. PubMed ID: 30201740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment Perspectives for Ovarian Cancer in Europe and the United States: Initial Therapy and Platinum-Sensitive Recurrence after PARP Inhibitors or Bevacizumab Therapy.
    Lainé A; Sims TT; Le Saux O; Ray-Coquard I; Coleman RL
    Curr Oncol Rep; 2021 Nov; 23(12):148. PubMed ID: 34751835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meeting report from the 2020 Annual (virtual) Meeting of the American Society of Clinical Oncology.
    Salani R; Liu JF
    Gynecol Oncol; 2020 Oct; 159(1):13-16. PubMed ID: 32771275
    [No Abstract]   [Full Text] [Related]  

  • 12. Shaping the standard of care in ovarian cancer management: A review of Gynecologic Oncology Group (GOG)/NRG oncology clinical trials of the past twenty years.
    DiSilvestro PA
    Gynecol Oncol; 2019 Jun; 153(3):479-486. PubMed ID: 30905435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International Gynecologic Cancer Society (IGCS) 2016: Meeting report.
    Del Carmen MG; Rice LW
    Gynecol Oncol; 2017 Jan; 144(1):11-15. PubMed ID: 27847107
    [No Abstract]   [Full Text] [Related]  

  • 14. The Evolving Arena of Ovarian Cancer Maintenance Therapy.
    Markman M
    Oncology; 2019; 97(4):202-205. PubMed ID: 31288226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of microscopic disease with hyperthermic intraoperative intraperitoneal chemotherapy after complete cytoreduction improves disease-free survival in patients with stage IIIC/IV ovarian cancer.
    Cascales-Campos PA; Gil J; Gil E; Feliciangeli E; González-Gil A; Parrilla JJ; Parrilla P
    Ann Surg Oncol; 2014 Jul; 21(7):2383-9. PubMed ID: 24599409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic therapy for ovarian cancer: current status and new treatments.
    Ozols RF
    Semin Oncol; 2006 Apr; 33(2 Suppl 6):S3-11. PubMed ID: 16716797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Not Available].
    Joly F; Querleu D; Namer M; Pujade-Lauraine E
    Bull Cancer; 2017 May; 104 Suppl 1():S1-S5. PubMed ID: 28625310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Single-Center, Retrospective Study of Bevacizumab-Containing Neoadjuvant Chemotherapy followed by Interval Debulking Surgery for Ovarian Cancer.
    Park J; Eoh KJ; Nam EJ; Kim S; Kim SW; Kim YT; Lee JY
    Yonsei Med J; 2020 Apr; 61(4):284-290. PubMed ID: 32233170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of hyperthermic intraperitoneal chemotherapy using paclitaxel in platinum-sensitive recurrent epithelial ovarian cancer patients with microscopic residual disease after cytoreduction.
    Cascales-Campos PA; Gil J; Feliciangeli E; Gil E; González-Gil A; López V; Ruiz-Pardo J; Nieto A; Parrilla JJ; Parrilla P
    Ann Surg Oncol; 2015 Mar; 22(3):987-93. PubMed ID: 25212832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a Simple and Safe Tumor Drilling Technique to Potentiate the Effect of Intraperitoneal Chemotherapy in the Treatment of Recurrent Epithelial Ovarian, Tubal, and Peritoneal Cancer: A Matched Retrospective Cohort Study.
    Chao WT; Chien CH; Lai CR; Wu HJ; Chuang CM
    Cancer Control; 2019; 26(1):1073274819863778. PubMed ID: 31343898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.